Anebulo Pharmaceuticals I...

NASDAQ: ANEB · Real-Time Price · USD
1.04
-0.04 (-3.70%)
At close: Jun 04, 2025, 12:14 PM

Anebulo Pharmaceuticals Statistics

Share Statistics

Anebulo Pharmaceuticals has 41.08M shares outstanding. The number of shares has increased by 58.43% in one year.

Shares Outstanding 41.08M
Shares Change (YoY) 58.43%
Shares Change (QoQ) 58.43%
Owned by Institutions (%) 87.03%
Shares Floating n/a
Failed to Deliver (FTD) Shares 1,186
FTD / Avg. Volume 4.34%

Short Selling Information

The latest short interest is 33.84K, so 0.08% of the outstanding shares have been sold short.

Short Interest 33.84K
Short % of Shares Out 0.08%
Short % of Float 0.48%
Short Ratio (days to cover) 2.46

Valuation Ratios

The PE ratio is -8.44 and the forward PE ratio is -2.19. Anebulo Pharmaceuticals's PEG ratio is 0.26.

PE Ratio -8.44
Forward PE -2.19
PS Ratio 0
Forward PS n/a
PB Ratio 18.15
P/FCF Ratio -8.55
PEG Ratio 0.26
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Anebulo Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.46, with a Debt / Equity ratio of 0.

Current Ratio 13.46
Quick Ratio 13.46
Debt / Equity 0
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -54.94

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-4,100,851.5
Employee Count 2
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -48.58% in the last 52 weeks. The beta is -1.16, so Anebulo Pharmaceuticals's price volatility has been lower than the market average.

Beta -1.16
52-Week Price Change -48.58%
50-Day Moving Average 1.1
200-Day Moving Average 1.52
Relative Strength Index (RSI) 49.86
Average Volume (20 Days) 27,353

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -8.31M
Net Income -8.2M
EBITDA -8.05M
EBIT -8.05M
Earnings Per Share (EPS) -0.32
Full Income Statement

Balance Sheet

The company has 3.09M in cash and 0 in debt, giving a net cash position of 3.09M.

Cash & Cash Equivalents 3.09M
Total Debt n/a
Net Cash n/a
Retained Earnings -65.4M
Total Assets 14.01M
Working Capital 13.38M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.09M and capital expenditures 0, giving a free cash flow of -8.09M.

Operating Cash Flow -8.09M
Capital Expenditures n/a
Free Cash Flow -8.09M
FCF Per Share -0.31
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ANEB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for ANEB is $5.5, which is 404.6% higher than the current price. The consensus rating is "Buy".

Price Target $5.5
Price Target Difference 404.6%
Analyst Consensus Buy
Analyst Count 2
Stock Forecasts

Scores

Altman Z-Score 40.84
Piotroski F-Score 2